ATC Group: V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V08AB in the ATC hierarchy

Level Code Title
1 V Various
2 V08 Contrast media
3 V08A X-ray contrast media, iodinated
4 V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media

Group V08AB contents

Code Title
V08AB01 Metrizamide
V08AB02 Iohexol
V08AB03 Ioxaglic acid
V08AB04 Iopamidol
V08AB05 Iopromide
V08AB06 Iotrolan
V08AB07 Ioversol
V08AB08 Iopentol
V08AB09 Iodixanol
V08AB10 Iomeprol
V08AB11 Iobitridol
V08AB12 Ioxilan

Active ingredients in V08AB

Active Ingredient Description
Iobitriol

Iobitriol is a urographic and angiographic water-soluble nonionic contrast agent.

Iodixanol
Iohexol

Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.

Iomeprol
Iopamidol

Iopamidol is contrast medium belonging to the new generation of non-ionic compound whose solubility is due to the presence of hydrophilic substitutes in the molecule. This results in a solution of low osmollity when compared with ionic media.

Iopromide

The contrast-giving substance in the iopromide formulations is iopromide, a non-ionic water-soluble derivative of triiodinated isophthalic acid in which the firmly bound iodine absorbs the X-rays. Injection of iopromide opacifies those vessels or body cavities in the path of flow of the contrast agent, permitting radio-graphic visualization of the internal structures until significant dilution occurs.

Iotrolan
Ioversol

Ioversol is a non-ionic X-ray contrast medium. Intravascular injection of ioversol opacifies those vessels in the path of the flow of the contrast medium, permitting radiographic visualisation of the internal structures until significant haemodilution occurs.

Ioxaglate

Related product monographs

Title Information Source Document Type  
GASTROMIRO Solution for oral or rectal administration Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
IOMERON Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ISOVUE 200/250/300/370 Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
NIOPAM Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
OMNIPAQUE Solution Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
OPTIRAY Solution for injection or infusion Health Products Regulatory Authority (IE) MPI, EU: SmPC
ULTRAVIST Solution for injection Health Products Regulatory Authority (IE) MPI, EU: SmPC
VISIPAQUE Solution for injection Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
XENETIX Solution for injection MPI, EU: SmPC